Creator: Help Dementia Editorial Team
Published: 2026-04-23T14:32:52

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Scientists find sits at the center of this dementia and brain health question.

Scientists have identified a direct link between how efficiently the brain uses energy and the development of Alzheimer’s disease, marking a significant shift in understanding how the neurological condition develops. Recent research shows that when the brain’s ability to produce and maintain adequate energy—specifically through a molecule called NAD+—becomes compromised, it creates the conditions for Alzheimer’s to take hold and progress. This connection is not merely theoretical: when researchers restored NAD+ levels in animal models, they were able to reverse cognitive decline and restore normal brain function, suggesting that energy metabolism may be central to both how Alzheimer’s develops and how it might be treated. The emerging picture is remarkably different from earlier models of Alzheimer’s that focused primarily on the buildup of amyloid plaques and tau tangles.

Instead, neuroscientists are now recognizing that these hallmark features may be symptoms of a deeper problem—the brain’s energy crisis. A person with Alzheimer’s doesn’t simply have damaged brain cells; their brain cells are struggling to produce the fuel they need to function. Understanding this energetic failure opens new possibilities for intervention that go beyond slowing disease progression to actually reversing the damage already done. This discovery comes after decades of research into Alzheimer’s mechanisms, and it fundamentally reframes how we should think about prevention and treatment. Rather than viewing the disease as an inevitable consequence of aging or genetics, researchers are revealing that Alzheimer’s may be more preventable and potentially reversible than previously believed—if we can address the energy deficit that drives it.

What Role Does Brain Energy Play in Alzheimer’s Development?
How Does Tau Protein Hijack the Brain’s Energy Supply?
Understanding NAD+ Depletion and Brain Energy Restoration
The APOE4 Genetic Variant and Energy Metabolism Disruption
The Role of Astrocyte Dysfunction and Free Radical Damage
The Hidden Energy Source Fueling Dementia Progression
Future Directions and the Promise of Metabolic Therapies
Conclusion

What Role Does Brain Energy Play in Alzheimer’s Development?

The brain is an extraordinarily energy-intensive organ, consuming roughly 20% of the body’s total energy despite representing only about 2% of body weight. Every thought, memory, and movement your brain orchestrates requires a constant supply of chemical energy in the form of ATP and related molecules like NAD+. Recent research reveals that in Alzheimer’s disease, this energy production system begins to fail—and this failure may be the root cause rather than a consequence of neurological decline. NAD+ is a critical molecule that acts as an electron shuttle in cells, enabling the production of ATP, the universal currency of cellular energy. When NAD+ levels drop—as researchers have documented in Alzheimer’s brains—neurons lose their ability to generate adequate energy.

Starved of fuel, brain cells cannot maintain their connections with other neurons, cannot clear out waste products, and eventually begin to die. In animal models, when scientists artificially restored NAD+ levels, damaged neurons recovered, synaptic connections reformed, and cognitive function returned to normal. This is not merely slowing the disease; this is reversal. The implication is profound: if energy deficit is the fundamental problem in Alzheimer’s, then treatments focused on restoring brain energy metabolism might work where amyloid-targeting drugs have largely failed. The brain’s energy crisis appears to be the upstream cause that triggers the downstream accumulation of amyloid plaques and tau tangles—not the other way around. This reorientation has already begun shifting research priorities and pharmaceutical development toward metabolic interventions.

What Role Does Brain Energy Play in Alzheimer's Development?

How Does Tau Protein Hijack the Brain’s Energy Supply?

One of the most striking discoveries in recent Alzheimer’s research is that the tau protein—long known as a hallmark of the disease—doesn’t simply damage neurons passively. Instead, tau actively and deliberately hijacks the brain‘s energy system, diverting glucose and other fuel sources away from normal cellular functions. University of Kentucky researchers have shown that tau protein forces the brain into a state of hyperexcitability, where neurons fire excessively and cannot enter the restorative rest states necessary for memory consolidation and cellular repair. When tau takes control of cellular energy metabolism, it redirects glucose that would normally fuel ATP production into the synthesis of glutamate, an excitatory neurotransmitter. This creates a vicious cycle: the brain becomes overexcited, consumes energy faster while producing less, and descends deeper into energy crisis.

Neurons in this state are like an engine running at redline continuously—they overheat, wear out faster, and cannot perform normal maintenance. The excessive glutamate also contributes to neuroinflammation, further damaging surrounding tissue and spreading tau pathology to adjacent neurons. What makes this mechanism particularly problematic is that it’s self-perpetuating. As tau spreads through the brain and commandeers more and more of the energy supply, the energy deficit worsens, making neurons more vulnerable to further tau accumulation. Breaking this cycle requires not just removing tau but restoring normal energy metabolism so that neurons can recover from the damage tau has already caused. Early interventions targeting both energy restoration and tau clearance appear more promising than attempting to address either problem alone.

Understanding NAD+ Depletion and Brain Energy Restoration

NAD+ (nicotinamide adenine dinucleotide) exists in multiple forms in the body, and its levels naturally decline with age in all tissues, including the brain. However, Alzheimer’s disease appears to accelerate this decline dramatically—NAD+ levels in Alzheimer’s brains are significantly lower than what would be expected for age alone. This accelerated depletion seems to occur through multiple pathways: some neurons lose their ability to synthesize NAD+, while others exhaust their NAD+ stores through stress responses and attempts to repair damage. The result is a double hit—the brain both produces less NAD+ and consumes it faster. The breakthrough came when researchers discovered that this process is partially reversible. By supplementing NAD+ or by blocking enzymes that break down NAD+, scientists were able to restore cellular energy production in animal models of Alzheimer’s disease. When energy production was restored, the brain’s natural repair mechanisms reactivated.

Damaged mitochondria—the cellular powerhouses—regained function. Synaptic connections between neurons reformed. Proteins associated with learning and memory, like BDNF, rebounded to normal levels. Within weeks, mice that had demonstrated severe cognitive decline recovered full memory function, a result that stunned the research community because Alzheimer’s had previously been considered irreversible. However, an important limitation must be acknowledged: all of these reversibility studies have been conducted in animal models, not in humans. Mice and rats have simpler brains and shorter lifespans, making it easier to observe recovery. Human brains are vastly more complex, and Alzheimer’s in humans develops over decades, potentially creating pathological changes that cannot be reversed even if energy is restored. Clinical trials in humans are necessary to determine whether NAD+-restoring therapies can actually reverse cognitive decline in patients, or whether they can at least slow progression if started early.

Understanding NAD+ Depletion and Brain Energy Restoration

The APOE4 Genetic Variant and Energy Metabolism Disruption

The APOE4 gene variant has long been known as a major genetic risk factor for Alzheimer’s disease—people carrying one copy of APOE4 have a higher risk, and those with two copies face even higher risk. Recent research reveals why: APOE4 disrupts the brain’s lipid metabolism and energy supply at a fundamental level. The brain normally relies on two fuel sources—glucose and lipids (fats). When glucose becomes scarce, neurons should be able to switch to burning fat for energy through a process called ketone metabolism. This metabolic flexibility is crucial during times of fasting, sleep, or stress. APOE4 variants prevent neurons from making this metabolic switch effectively. When blood glucose drops, neurons carrying APOE4 cannot access alternative fuel sources and face an energy crisis.

Over a lifetime, this impaired metabolic flexibility means that APOE4-positive individuals experience repeated episodes of neuronal energy shortage. Each episode damages synapses and mitochondria, and over decades, this accumulated damage contributes to cognitive decline. In contrast, people with the APOE2 or APOE3 variants maintain better metabolic flexibility and can sustain energy production through multiple fuel sources. The practical implication is that people with APOE4 may benefit from different preventive strategies than the general population. They might benefit from dietary approaches that support metabolic flexibility, such as intermittent fasting or ketogenic diets, which train the brain to use alternative fuels efficiently. Additionally, therapies that restore NAD+ or improve mitochondrial function might be particularly valuable for APOE4 carriers. This represents a shift toward personalized approaches to Alzheimer’s prevention based on genetic risk factors—one size does not fit all.

The Role of Astrocyte Dysfunction and Free Radical Damage

While neurons receive most of the attention in Alzheimer’s research, recent discoveries have highlighted the critical role of astrocytes—star-shaped support cells that outnumber neurons in the brain and are responsible for providing energy substrates and nutrients. Weill Cornell Medicine researchers have identified that free radicals generated within astrocytes contribute significantly to neuronal damage and dementia development. These reactive oxygen species leak from astrocytes and damage nearby neurons, particularly their mitochondria, further impairing energy production. Astrocytes normally provide lactate and other fuel molecules to neurons, essentially serving as energy suppliers. In Alzheimer’s disease, dysfunctional astrocytes fail to deliver adequate fuel, while simultaneously generating damaging free radicals. This creates a double threat: the neurons are simultaneously starved and poisoned.

Furthermore, astrocyte dysfunction contributes to neuroinflammation, as activated astrocytes release inflammatory molecules that recruit immune cells to the brain. This neuroinflammatory response, while initially protective, becomes chronic and destructive in Alzheimer’s disease. A critical limitation in understanding astrocyte dysfunction is that most research has focused on neurons, and therapeutic strategies have been correspondingly neuron-centric. Drugs that work perfectly on isolated neurons may fail in the brain because they don’t address underlying astrocyte problems. Future therapies may need to specifically target astrocyte health, supporting these critical support cells in energy production and reducing their generation of free radicals. This represents a significant gap in current Alzheimer’s treatment approaches.

The Role of Astrocyte Dysfunction and Free Radical Damage

The Hidden Energy Source Fueling Dementia Progression

In November 2025, researchers made an unexpected discovery: the brain has a previously unknown source of energy that feeds dementia development. While the exact nature of this mechanism has not been fully detailed in public reports, it appears to represent an alternative metabolic pathway that becomes active during Alzheimer’s disease and somehow contributes to its progression.

This finding emerged from systematic analysis of metabolic changes in Alzheimer’s brains and represents the kind of discovery that can fundamentally shift therapeutic approaches. The existence of this hidden energy source raises intriguing questions: Is it a pathological adaptation that allows damaged neurons to temporarily maintain function while accelerating their eventual death? Is it a metabolic pathway that preferentially fuels the production of harmful proteins like amyloid and tau? Understanding this pathway could reveal new intervention points and explain why some previous therapies have failed—they may have addressed one energy crisis while the brain shifted to this alternative pathway. Further research will be necessary to characterize this mechanism and develop therapies targeting it.

Future Directions and the Promise of Metabolic Therapies

The convergence of these research findings—NAD+ depletion, tau energy hijacking, APOE4 metabolic dysfunction, astrocyte pathology, and hidden energy sources—points toward a new era of Alzheimer’s research centered on metabolic restoration rather than protein clearance. While the amyloid hypothesis dominated research for two decades with limited clinical success, the energy metabolism hypothesis offers something the amyloid hypothesis did not: the possibility of reversal rather than merely slowing decline.

Multiple research teams are now pursuing metabolic therapies, including NAD+ boosters, molecules that enhance mitochondrial function, supplements that support alternative fuel metabolism, and approaches that reduce free radical damage in astrocytes. Clinical trials in humans should begin in the coming years to test whether these animal model successes translate to actual cognitive recovery in Alzheimer’s patients. The timeline is uncertain—drug development is inherently slow and many promising animal studies fail to produce clinical results—but the conceptual shift has already begun reshaping how the field thinks about Alzheimer’s prevention and treatment.

Conclusion

The emerging understanding of Alzheimer’s as fundamentally a disease of brain energy metabolism represents one of the most significant shifts in neuroscience in recent decades. Rather than viewing cognitive decline as an inevitable consequence of aging or an irreversible cascade of protein misfolding, researchers now see the disease as potentially preventable and even reversible if the underlying energy deficit can be addressed. The evidence from animal models demonstrating full cognitive recovery when NAD+ is restored provides hope that this insight will eventually translate to human therapies.

The path forward requires continued research to understand how these metabolic mechanisms work in the human brain and to develop safe, effective therapies that can restore normal brain energy metabolism. For people concerned about cognitive health, this research suggests that supporting brain energy metabolism—through diet, exercise, metabolic flexibility, and eventually through targeted medications—may be more effective than strategies focused purely on clearing amyloid. As these new therapies move through clinical trials over the coming years, we may finally have tools that meaningfully address Alzheimer’s disease rather than merely slowing its progression.